| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |